Weiqi Hong
Molecular Biology · 2020–2022
A researcher in the Science corpus: 3 papers; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 135 citations into it
- Oncology — 66 citations into it
- Cancer Research — 30 citations into it
Whom Weiqi Hong trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- R. Weinberg (in Oncology)
- Feng Zhang (in Molecular Biology)
- M. Nieto (in Molecular Biology)
- V. Mittal (in Oncology)
Papers from Weiqi Hong's perspective
Ordered by how strongly the researchers Weiqi Hong trusts endorse each paper. Same corpus, a different order for every researcher.
- The epithelial-mesenchymal transition generates cells with properties of stem cells. (Cell)
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 (Nature Cell Biology)
- Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. (Cell)
- Epithelial-mesenchymal transitions in development and disease. (Cell)
- The Snail genes as inducers of cell movement and survival: implications in development and cancer (Development)
- Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits (Nature Reviews. Cancer)
- Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? (Nature Reviews. Cancer)
- The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression (Nature Cell Biology)
- A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells (EMBO Reports)
- Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. (Cancer Cell)
Their papers
- The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis (2022) — 851 citations
- A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity (2020) — 724 citations
- Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects (2020) — 1,313 citations